NSPR
InspireMD, Inc.
NASDAQ · ILHealthcareMedical - Devices
$0.70+0.33%
Price as of Jul 20, 2026
NSPR profitability
InspireMD, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 28.1%
- EBITDA margin
- -337.7%
- EBIT margin
- -480.6%
- Net margin
- -344.1%
- Free cash flow margin
- -370.1%
Returns
- Return on equity
- -85.6%
- Return on assets
- -66.1%
- Return on invested capital
- -111.6%
- Asset turnover
- 0.17x
Cash efficiency
- Cash from operations
- -$38.6M
- Cash per share
- $0.89
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.